Clinical trial
A Long-Term Follow-Up Safety Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02
NCT06488261 is registered in ClinicalTrials.gov with John Bernat as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term Follow-Up Safety Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02
- Lead sponsor
- John Bernat
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 21, 2024
- Completion date
- October 31, 2037
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.